Lemur tyrosine kinase-3 (LMTK3) as a target in oestrogen positive breast cancer

Affiliations

¹ Queensland University of Technology, Discipline of Medical Sciences, Faculty of Science and Technology, Brisbane, GPO 2343, QLD 4001, Australia. sheila.doggrell@qut.edu.au

Comment

Sheila A Doggrell. Expert Opin Ther Targets. 2011 Dec.

. 2011 Dec;15(12):1419-22.

doi: 10.1517/14728222.2011.632633. Epub 2011 Oct 28.

¹ Queensland University of Technology, Discipline of Medical Sciences, Faculty of Science and Technology, Brisbane, GPO 2343, QLD 4001, Australia. sheila.doggrell@qut.edu.au

No abstract available

Comment on

Kinome screening for regulators of the estrogen receptor identifies LMTK3 as a new therapeutic target in breast cancer.
Giamas G, Filipović A, Jacob J, Messier W, Zhang H, Yang D, Zhang W, Shifa BA, Photiou A, Tralau-Stewart C, Castellano L, Green AR, Coombes RC, Ellis IO, Ali S, Lenz HJ, Stebbing J. Giamas G, et al. Nat Med. 2011 Jun;17(6):715-9. doi: 10.1038/nm.2351. Epub 2011 May 22. Nat Med. 2011. PMID: 21602804
LMTK3 expression in breast cancer: association with tumor phenotype and clinical outcome.
Stebbing J, Filipovic A, Ellis IO, Green AR, D'Silva TR, Lenz HJ, Coombes RC, Wang T, Lee SC, Giamas G. Stebbing J, et al. Breast Cancer Res Treat. 2012 Apr;132(2):537-44. doi: 10.1007/s10549-011-1622-z. Epub 2011 Jun 14. Breast Cancer Res Treat. 2012. PMID: 21671015